IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Anticancer Research Editorial Board 2024

P.A. Abrahamsson Department of Urology, Skåne University Hospital, Lund University, Malmö, Sweden
B. B. Aggarwal Inflammation Research Center, San Diego, CA, USA
T. Akimoto Division of Partical Therapy and Department of Radiation Oncology, National Cancer Center East, Kashiwa, Chiba, Japan
P.Z. Anastasiadis Department of Cancer Biology, Mayo Cancer Center, Jacksonville, FL, USA
A. Argiris Division of Hematology/Oncology, UT Health Science Center at San Antonio, San Antonio, TX, USA
J. P. Armand Institut Gustave Roussy, Paris, France
V. I. Avramis Division of Hematology/Oncology, Childrens Hospital, Los Angeles, CA, USA
D.T. Bau Terry Fox Cancer Research Lab, China Medical University Hospital, Taichung, Taiwan
G. Bauer Abteilung Virologie, Institut für Medizinische Mikrobiologie und Hygiene, Universität Freiburg, Freiburg, Germany
E. E. Baulieu INSERM U488 and College de France, Le Kremlin-Bicetre, France
E. J. Benz, Jr. Dana-Farber Cancer Institute, Boston, MA, USA
J. Bergh Department of Clinical and Molecular Medicine, Radiumhemmet, Karolinska Institute, Stockholm, Sweden
J. Y. Blay Centre Léon Bérard, Lyon, France
F. T. Bosman Institute of Pathology, University of Lausanne,  Lausanne, Switzerland
M. Bouvet Department of Surgery, University of California San Diego, Moores Cancer Center, La Jolla, CA, USA
J. Boyd Department of Human and Molecular Genetics, Herbert Wertheim College of Medicine, Florida Int. University, Miami, FL, USA
G. Broich Gruppo Policlinico di Monza, Monza, Italy
Ø. S. Bruland Department of Medical Oncology-Radiotherapy, Norwegian Radium Hospital, Oslo, Norway
J.M. Buatti Department of Radiation Oncology, University of Iowa, Iowa City, IA, USA
M. Carbone Cancer Research Center of Hawaii, Honolulu, HI, USA
C. Carlberg Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland
A. F. Chambers Department of Oncology, London Regional Cancer Center, London, Ontario, Canada
P. Chandra Abt. für Molekularbiologie, Klinikum Wolfgang Goethe-Universität, Frankfurt am Main, Germany
L. Cheng Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA
J.-G. Chung Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, ROC
R. Clarke Department of Oncology, Georgetown University Medical Center, Washington, DC, USA
E. De Clercq Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium
A. P. Conley Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
E. P. Diamandis Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
G. Th. Diamandopoulos Department of Pathology, Harvard Medical School, Boston, MA, USA
J.M. Drake Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, USA
L. Egevad Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
D.W. Felsher Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA
H. Fu Department of Pharmacology, Emory University School of Medicine, Atlanta, GA, USA
B. Fuchs Balgrist University Hospital, Zurich, Switzerland
D. Fuchs Center for Chemistry and Biomedicine, Innsbruck Medical University, Innsbruck, Austria
E. L. Fukumura Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA
G. Gabbiani Department of Pathology, University of Geneva, Geneva, Switzerland
R. Ganapathi Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA
A. Giordano Sbarro Institute for Cancer Research, Temple University, Philadelphia, PA, USA
M. Gnant Department of Surgery, Medical University of Vienna, Vienna, Austria
R. H. Goldfarb Trudeau Institute, Saranac Lake, NY, USA
J.S. Greenberger Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, PA, USA
A. Helland Oslo University Hospital-Radium Hospital, Oslo, Norway
L. Helson Sign Path Pharma, Inc., Quakertown, PA, USA
R. Henriksson Department of Radiation Science, University of Umea, Umea, Sweeden
R. M. Hoffman Department of Surgery, University of California, San Diego, CA, USA
P. Hohenberger Division of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, Mannheim, Germany
F. Janku Monte Rosa Therapeutics, Boston, MA, USA
S. C. Jhanwar Laboratory of Solid Tumor Genetics, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
J. V. Johannessen Department of Pathology, the Norwegian Radium Hospital, Oslo, Norway
R. Jones Sarcoma Unit, Royal Marsden Hospital, London, UK
B. Kaina Institute of Toxicology, University of Mainz, Mainz, Germany
D. G. Kieback Helios Medical Center Schleswig, Schleswig, Germany
R. Klapdor Medical Clinic, University of Hamburg, Hamburg, Germany
K. L. Knutson Mayo Clinic, Jacksonville, FL, USA
H. Kobayashi Laboratory of Molecular Theranostics, NCI/NIH, Bethesda, MD, USA
S. D. Kottaridis Department of Virology, Hellenic Anticancer Institute, Athens, Greece
G. R. F. Krueger Center of Anatomy II, University of Cologne Medical School, Cologne, Germany
Pat Kumar Department of Biological Sciences, Manchester Metropolitan University, Manchester, UK
Shant Kumar Department Pathology, University of Manchester Medical School, Manchester, UK
O. D. Laerum Department of Pathology, the Gade Institute, University of Bergen, Bergen, Norway
F. J. Lejeune Fondation du Centre Pluridisciplinaire d’ Oncologie, CHUV, Lausanne, Switzerland
S. Linder Department of Medicine and Health, Linköping University, Linköping, Sweden
D. M. Lopez Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL, USA
E. Lundgren Unit of Applied Cell and Molecular Biology, University of Umeå, Umeå, Sweden
Y. Maehara Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
J. Maher Department of Research Oncology, Division of Cancer Studies, King’s College London School of Medicine, Guy’s Hospital Campus, London, UK
J. Marescaux IRCAD, University of Strasbourg, Strasbourg, France
S.S. Martin Department of Physiology, University of Maryland, School of Medicine, Baltimore, MD, USA
S. Mitra Houston Methodist Research Institute, Houston, TX, USA
S. Miyamoto Department of Obstetrics and Gynecology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
S. Moncada Manchester Cancer Research Centre, University of Manchester, Manchester, UK
M. Mueller Hochschule Furtwangen University, Villingen-Schwenningen, Germany
M. Namiki Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa City, Ishikawa, Japan
K. Nilsson Rudbeck Laboratory, Department of Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden
S. Pathak Department of Cell Biology, University of Texas, Houston, TX, USA
J.L. Persson
Section for Experimental Cancer Research, Clinical Research Center, Lund University, Malmö, Sweden
G. J. Pilkington Department of Cellular and Molecules Neurooncology, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK
C. D. Platsoucas College of Sciences, Old Dominion University, Norfolk, VA, USA
A. Polliack Department of Haematology, Hadassah University Hospital and Medical School, Jerusalem, Israel
D. Rades Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
M. Rigaud Laboratory Biochimie et Génétique Molecules, Faculté de Médecine de Limoges, Limoges, France
U. Ringborg Department of General Oncology, Karolinska Hospital, Stockholm, Sweden
M. Roselli Department of Medical Oncology, University of Rome “Tor Vergata”, Rome, Italy
S.T. Rosen Comprehensive Cancer Center & Beckman Research Institute, Duarte, CA, USA
M. Schauer Visceral and Thoracic Surgery, Augusta Krankenhaus, Düsseldorf, Germany
M. Schneider Department of Organic Chemistry, Bergische University, Wuppertal, Germany
J. Sehouli Department of Gynecology with Center for Oncological Surgery, Charité Comprehensive Cancer Center (CCCC), Berlin, Germany
A. Seth Laboratory of Molecular Pathology, Sunnybrook Research Institute and University of Toronto, Ontario, Canada
G. V. Sherbet Cancer Research Unit, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, UK
A. Slominski Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA
G.-I. Soma Department of Integrated and Holistic Immunology, Faculty of Medicine, Kagawa University, Kagawa, Japan
G. S. Stein Department of Biochemistry, College of Medicine, University of Vermont, Burlington, VT, USA
T. Stigbrand Department of Immunology, Umeå University, Umeå, Sweden
T. M. Theophanides Department of Chemistry, Technical University of Athens, Athens, Greece
P. M. Ueland Clinical Pharmacolocy Unit, Department of Pharmacology, University of Bergen, Bergen, Norway
H. Van Vlierberghe Department of Gastroenterology and Hepatology, Ghent University Hospital, Ghent, Belgium
R.G. Vile Department of Immunology, Mayo Clinic, Rochester, MN, USA
M. Weller Department of Neurology, University Hospital Zurich, Zurich, Switzerland
B. Westermark Rudbecklaboratoriet, Department of Genetics and Pathology, University of Uppsala, Uppsala, Sweden
J. Westermarck Center for Biotechnology, University of Turku, Turku, Finland
Y. Yen Taipei Medical University, Taipei, Taiwan, ROC
M.R.I. Young Ralph H. Johnson VA Medical Center, Medical University of South Carolina, Charleston, SC, USA
G.J. Delinasios IIAR, Managing Editor
J.G. Delinasios IIAR, Managing Editor (1981-2016)

IMPORTANT NOTE: You may submit your article only through our online submission system